Document 1Qg4YMbgyxjGnMDDkyVD41pXK

- - ~i / ---------------- 3T-- April!, 195* Or* Kenneth W. Smith, Medical Director Johas*Maavtlle Corporation 22 Cut 40th St:it . New York 10. New York \ 8ui Xoi '. . I w v<fy glad to Utn from year Utter ef Merck 22 tket ear proposal lor a ready of tke yrohUm la Quebec nit with year approval* I appreciate year suggestion that It may be poeaible to follow a fairly large group of employeea for mesa than Ike 20 yeara I suggested* Ike greater somber of people that caa be Included. and the longer the time ever which they caa be add ted, the mere accurate ' the dedactloaa caa be. ' With regard to the atartlag data which l failed ta include* X waa poaalbly hedging n Uttle antil 1 waa in n bettar petition to aatU mate my achodulo. At the time the propeeal wae made, there waa the poealbUlty of your own medical aarvey and we were antUlpatiag the otady for the Tensile laotltute which we knew might hnve acme arena of Malignity with the Quebec study. Since our meeting loot week with Hugh and Ur. Holman, 1 have a better Idea of the latter end Hugh telle me that the medical survey for J-M would meet likely give precedence to the lung caaeer study. With this in mind, I believe we could antlet* pats starting iba study by the Utter pert ef May. if U is approved. So fir an I am able to say at this time, it wtU likely require the greater part ef a year to collect and analyse the data and n few months more to prepare the report. Kindest per tonal regard*. Sincerely, DCStds Daniel C. Braun. U.O. Medical Director / 0421